Damage to joint cartilage in dogs is a serious orthopaedic problem that leads to pain, lameness and gradual loss of mobility. It can result from injury, overuse, congenital joint defects or as a complication of osteoarthritis. Cartilage has a very limited ability to regenerate itself, which is why standard treatment is often not fully effective.
The classic approach involves anti-inflammatory pharmacotherapy, cartilage-supporting supplements and rehabilitation. In more severe cases, surgical treatment may be necessary. However, the problem remains that traditional methods are unable to rebuild damaged cartilage, but only alleviate the symptoms.
MSCs are currently the most important tool in cartilage regeneration. They secrete trophic factors and differentiate into chondrocytes, supporting the reconstruction of the cartilage matrix. This makes it possible to:
slow down the degenerative process, improve joint structure and function, reduce pain and restore mobility.
👉 Check out how mesenchymal stem cells work
PRP contains high concentrations of growth factors that support the repair of periarticular tissues and reduce inflammation. In cases of cartilage damage, PRP is used as a supportive therapy in the early stages of the disease.
👉 Learn more about PRP
Stage 1 – minor damage: PRP as a method of reducing inflammation and supporting repair processes.
Stage 2 – moderate and extensive damage: MSC as the only effective method of cartilage regeneration.
Stage 3 – advanced changes: combination of MSC with rehabilitation and, if necessary, reconstructive surgery.
Damage to joint cartilage in dogs is a difficult therapeutic challenge. Modern biological therapies, such as PRP and MSC, not only alleviate symptoms, but also have a real impact on joint regeneration. Thanks to them, dogs can regain their fitness and comfort of life.
No – its regenerative abilities are very limited, which is why biological therapies are needed.
PRP is used in the early stages of the disease, and MSC in moderate to severe damage.
Reduction of pain, improvement of mobility and restoration of cartilage structure.
Yes, PRP and MSC utilise the patient's own tissue, which minimises the risk of adverse reactions.
